glp-1 drugs long term side effects nausea: How to handle GLP-1s' most common effect As GLP-1 drugs for obesity

In contrast, the obesity-specific analysis focuses on adolescents who meet the CDC definition of obesity and have no prior evidence of T2D

This is relevant for the short-acting GLP-1 agonists, whereas tachyphylaxis rapidly develops for the long-acting agonists [8]

Interestingly, female participants lost more weight than male participants over the 48 weeks, achieving 28.5% and 21.9% with 12 mg, respectively

Keep track of any side effects weekly if theyre minimal, discuss a potential dose escalation with your doctor

[DOI] [PMC free article] [PubMed] [Google Scholar] 94.Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity